FDA Adverse Event Malfunction Summary report: N

CAPIOX FX OXYGENATOR

MDR report key: 10137233 · Received June 10, 2020

Report

Report Number
9681834-2020-00112
Event Type
Malfunction
Date Received
June 10, 2020
Report Date
June 10, 2020
Manufacturer
TERUMO CORPORATION, ASHITAKA
Product Code
DTZ
PMA / PMN Number
K071494
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
JA
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

DATE OF EVENT: REQUESTED, NOT PROVIDED, LOT NUMBER: REQUESTED, NOT PROVIDED, EXPIRATION DATE - UNKNOWN DUE TO UNKNOWN LOT NUMBER, UDI - NOT REQUIRED FOR PRODUCT CODE, IMPLANTED DATE: DEVICE WAS NOT IMPLANTED, EXPLANTED DATE: DEVICE WAS NOT EXPLANTED, DEVICE MANUFACTURE DATE - UNKNOWN DUE TO UNKNOWN LOT NUMBER. 510K - K130520. THE ACTUAL DEVICE WAS NOT RETURNED; THEREFORE, AN EVALUATION OF THE ACTUAL DEVICE WAS UNABLE TO BE CONDUCTED. THE PRODUCTION LOT NUMBER WAS NOT PROVIDED BY THE USER FACILITY, WHICH PREVENTED A MEANINGFUL REVIEW OF THE DEVICE HISTORY RECORD AND PRODUCT RELEASE DECISION CONTROL SHEET. WITH NO RETURN OF THE ACTUAL DEVICE, THE EXACT CAUSE OF THE REPORTED EVENT CANNOT BE DEFINITIVELY DETERMINED BASED ON THE AVAILABLE INFORMATION. TERUMO MEDICAL PRODUCTS (TMP) (IMPORTER) REGISTRATION NO. (B)(4) IS SUBMITTING THIS REPORT ON BEHALF OF ASHITAKA FACTORY OF TERUMO CORPORATION (MANUFACTURER) REGISTRATION NO. (B)(4).

Description of Event or Problem · 1

THE USER FACILITY REPORTED THAT THE INVOLVED CAPIOX CUSTOM PACK WAS USED PRE-TREATMENT. DURING A PRIMING WITH THE TEMPERATURE SET TO 36°C, THE VENOUS BLOOD TEMPERATURE WAS SHOWN AS 35.5°C WHEREAS THE ARTERIAL TEMPERATURE WAS SHOWN 34.7°C - 35.2°C. THIS PHENOMENON OCCURRED AFTER THE S5 MODULE WAS CHANGED. THE FINAL PATIENT IMPACT AND PROCEDURE OUTCOME WERE NOT REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
600935 CAPIOX FX OXYGENATOR OXYGENATOR, CARDIOPULMONARY BYPASS DTZ TERUMO CORPORATION, ASHITAKA NA UNK

Patients

Seq Age Sex Outcome Treatment
1